A study on ACE2 knockout mice provides a molecular explanation of why SARS-CoV infections cause severe and often lethal lung failure and suggests a rational therapy with recombinant ACE or with drugs that increase angiotensin II and ACE2 (Imai et al., 2005; Murthy et al., 2020). This evidence concerns the gene ACE2 and severe acute respiratory syndrome.